Boardroom Alpha
Boardroom Alpha
BRSP · Current Report (Form 8-K) · Filed May 20, 2026

Brightspire Capital Inc — Current Report (Form 8-K)

Form
8-K
Filed
May 20, 2026
Period
May 19, 2026
Ticker
BRSP
Accession
0001717547-26-000050
Boardroom Alpha · Filing insights

CEO Mazzei's contract extended to 2030; 2027–2029 bonus and LTIP targets reduced.

About Brightspire Capital Inc
Market cap
$727M
1Y TSR
+24.7%
3Y TSR
+7.8%
Board grade
C
Sector
Real Estate
CEO
Michael Mazzei
Last annual meeting: May 13, 2026 · View full Brightspire Capital Inc profile →
brsp-20260519

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): May 19, 2026
 
BrightSpire Capital, Inc.
(Exact name of registrant as specified in its charter)
 
Maryland001-3837738-4046290
(State or other jurisdiction(Commission(IRS Employer
of incorporation)File Number)Identification No.)
 
590 Madison Avenue, 33rd Floor
New York, NY 10022
(Address of Principal Executive Offices, Including Zip Code)

Registrant’s telephone number, including area code: (212) 547-2631

Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
            Soliciting material pursuant to Rule l4a-12 under the Exchange Act (17 CFR 240.14a-12)
 
            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s)Name of each exchange on which registered
Class A common stock, par value $0.01 per shareBRSPNew York Stock Exchange
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 5.02.            Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers.
 
Mazzei Employment Agreement

On February 16, 2024, the Company entered into a second amended and restated employment agreement with Michael Mazzei, Chief Executive Officer (the “Second Amended and Restated Employment Agreement”), pursuant to which Mr. Mazzei’s term of employment expires on March 31, 2027. Thereunder, Mr. Mazzei receives an annual base salary of $800,000, an annual target cash bonus opportunity (“Annual Cash Bonus”) of no less than $1,750,000, and an annual target long-term equity incentive opportunity (“Annual LTIP Award”) of no less than $3,000,000.

On May 19, 2026, the Company and Mr. Mazzei entered into a First Amendment (the “First Amendment”) to the Second Amended and Restated Employment Agreement, to extend the term of employment to March 31, 2030. In addition, Mr. Mazzei agreed to (A) reduce his Annual Cash Bonus opportunity for calendar years 2027 to 2029 to no less than: 2027 - $1,575,000; 2028 - $1,450,000; and 2029 - $1,375,000, and (B) reduce his target Annual LTIP Award for calendar years 2027 to 2029 to no less than: 2027 - $2,700,000; 2028 - $2,475,000; and 2029 - $2,375,000.

The foregoing description of certain terms of the Second Amended Employment Agreement and First Amendment do not purport to be complete and are qualified in their entirety by reference to the full text of (i) the Second Amended Employment Agreement, which is filed as Exhibit 10.58 to the Company's Annual Report on Form 10-K on February 21, 2024, and (ii) the First Amendment, a copy of which is attached hereto as Exhibit 10.1.

 
Item 9.01.            Financial Statements and Exhibits.
(d) Exhibits. The following exhibits are being furnished herewith to this Current Report on Form 8-K.
Exhibit No.
 
Description
10.1
 
104Cover Page Interactive Data File (embedded within the Inline XBRL document)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: May 20, 2026BRIGHTSPIRE CAPITAL, INC.
By:
/s/ David A. Palamé
David A. Palamé
General Counsel and Secretary





From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Brightspire Capital Inc (BRSP)

Reference

Frequently asked questions

When did Brightspire Capital Inc file this 8-K?
Brightspire Capital Inc (BRSP) filed this Current Report (Form 8-K) with the SEC on May 20, 2026. The accession number assigned by EDGAR is 0001717547-26-000050.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
CEO Mazzei's contract extended to 2030; 2027–2029 bonus and LTIP targets reduced. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Brightspire Capital Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Brightspire Capital Inc has filed under CIK 1717547, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer